DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Blank A, Markert C, Hohmann N. , et al.
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B.
J Hepatol 2016;
65 (03) 483-489
We do not assume any responsibility for the contents of the web pages of other providers.